A61P 31/12
Antivirals
A61P31/12 (Antivirals) appears on 32,392 US grants and 49,498 published applications in this corpus.
Search patents in A61P- Granted patents
- 32,392
- Published applications
- 49,498
- Assignees
- 12,177
- Inventors
- 71,774
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 15 | 0 |
| 1978 | 13 | 0 |
| 1979 | 11 | 0 |
| 1980 | 20 | 0 |
| 1981 | 15 | 0 |
| 1982 | 23 | 0 |
| 1983 | 12 | 0 |
| 1984 | 16 | 0 |
| 1985 | 30 | 0 |
| 1986 | 22 | 0 |
| 1987 | 32 | 0 |
| 1988 | 34 | 0 |
| 1989 | 76 | 0 |
| 1990 | 68 | 0 |
| 1991 | 94 | 0 |
| 1992 | 99 | 0 |
| 1993 | 97 | 0 |
| 1994 | 94 | 0 |
| 1995 | 162 | 0 |
| 1996 | 240 | 0 |
| 1997 | 371 | 0 |
| 1998 | 505 | 0 |
| 1999 | 592 | 0 |
| 2000 | 622 | 0 |
| 2001 | 684 | 176 |
| 2002 | 687 | 873 |
| 2003 | 741 | 1553 |
| 2004 | 531 | 1814 |
| 2005 | 515 | 1854 |
| 2006 | 767 | 1775 |
| 2007 | 777 | 1947 |
| 2008 | 859 | 2140 |
| 2009 | 1056 | 2443 |
| 2010 | 1381 | 3039 |
| 2011 | 1405 | 2879 |
| 2012 | 1710 | 2743 |
| 2013 | 1756 | 2065 |
| 2014 | 1954 | 2190 |
| 2015 | 1600 | 1928 |
| 2016 | 1513 | 1954 |
| 2017 | 1545 | 1843 |
| 2018 | 1376 | 1832 |
| 2019 | 1389 | 1878 |
| 2020 | 1268 | 1671 |
| 2021 | 1199 | 1841 |
| 2022 | 1030 | 1858 |
| 2023 | 922 | 2661 |
| 2024 | 950 | 2107 |
| 2025 | 892 | 1534 |
| 2026 | 614 | 900 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of treating influenza and poxvirus viral infections6 Oct 2026US 12,751,942 B2Veru Inc.
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Application of TFF2 protein and IFN-κ protein combination in treatment of a novel coronavirus infection6 Oct 2026US 12,751,996 B2Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- Immunostimulatory adjuvants6 Oct 2026US 12,752,000 B2Orionis Biosciences BV
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Antiviral infusion composition8 Oct 2026US 2026/0306518 A1
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306563 A1Societe des Produits Nestle S. A.
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306564 A1Societe des Produits Nestle S. A.
- Production method8 Oct 2026US 2026/0306577 A1AG IP Company Pty Ltd
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998